Linden Thomas Advisory Services LLC increased its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,540 shares of the company’s stock after buying an additional 149 shares during the period. Linden Thomas Advisory Services LLC’s holdings in DocuSign were worth $1,218,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Modus Advisors LLC bought a new stake in shares of DocuSign during the fourth quarter worth approximately $36,000. Itau Unibanco Holding S.A. acquired a new position in DocuSign during the third quarter valued at approximately $28,000. Brooklyn Investment Group acquired a new position in DocuSign during the third quarter valued at approximately $33,000. Avior Wealth Management LLC grew its holdings in DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares during the period. Finally, Friedenthal Financial acquired a new position in DocuSign during the fourth quarter valued at approximately $54,000. 77.64% of the stock is owned by institutional investors.
DocuSign Price Performance
Shares of DOCU opened at $91.60 on Friday. The firm has a market capitalization of $18.51 billion, a PE ratio of 18.89, a PEG ratio of 8.30 and a beta of 0.88. The company’s 50-day moving average is $89.76 and its 200-day moving average is $71.43. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.
Insider Activity
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the stock. HSBC restated a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Morgan Stanley upped their price target on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. JPMorgan Chase & Co. increased their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday, December 3rd. Piper Sandler increased their target price on shares of DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Finally, UBS Group increased their target price on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, DocuSign presently has a consensus rating of “Hold” and an average price target of $92.45.
Check Out Our Latest Analysis on DOCU
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- The Basics of Support and Resistance
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Invest in Insurance Companies: A GuideĀ
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.